Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. DEFA14A Proxy Proxy Materials
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. CT ORDER Other Confidential Order
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. EFFECT Other Notice of Effectiveness
  6. CT ORDER Other Confidential Order
  7. S-8 Other Securities Offered to Employees in Benefit Plans
  8. CT ORDER Other Confidential Order
  9. EFFECT Other Notice of Effectiveness
  10. CT ORDER Other Confidential Order
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. CT ORDER Other Confidential Order
  13. CERTNAS Other Certification by the Nasdaq Stock Market
  14. CERTNAS Other Certification by the Nasdaq Stock Market
  15. EFFECT Other Notice of Effectiveness
  16. CT ORDER Other Confidential Order
  17. POS AM Other Post-effective Amendment for Registration Statement
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. EFFECT Other Notice of Effectiveness
  20. CERTNAS Other Certification by the Nasdaq Stock Market

Page 4 of 5 · 83 filings